000 | 01969 a2200553 4500 | ||
---|---|---|---|
005 | 20250514064848.0 | ||
264 | 0 | _c20030515 | |
008 | 200305s 0 0 eng d | ||
022 | _a0041-1337 | ||
024 | 7 |
_a10.1097/01.TP.0000061791.71792.79 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDresske, Bettina | |
245 | 0 | 0 |
_aWOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. _h[electronic resource] |
260 |
_bTransplantation _cApr 2003 |
||
300 |
_a1286-91 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aCalcineurin Inhibitors |
650 | 0 | 4 | _aDaclizumab |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney _xphysiopathology |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
700 | 1 | _aZavazava, Nicholas | |
700 | 1 | _aJenisch, Stefan | |
700 | 1 | _aExner, Beate | |
700 | 1 | _aLenz, Philine | |
700 | 1 | _aEl Mokhtari, Nour Eddine | |
700 | 1 | _aKremer, Bernd | |
700 | 1 | _aFaendrich, Fred | |
773 | 0 |
_tTransplantation _gvol. 75 _gno. 8 _gp. 1286-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.TP.0000061791.71792.79 _zAvailable from publisher's website |
999 |
_c12508046 _d12508046 |